Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - Timber Pharmaceuticals, Inc. | tm2023963d1_8ka.htm |
 |
10 Almaden Boulevard, Suite 1000, San Jose, CA 95113
Phone (408) 961-6300 Fax (408) 961-6324 Email bpm@bpmcpa.com Web bpmcpa.com
|
Exhibit 16.1
June 30, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Timber Pharmaceuticals, Inc., which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Amendment No. 1 to the Form 8-K of Timber Pharmaceuticals, Inc. dated May 22, 2020. We agree with the statements concerning our Firm in such Amendment No. 1 to the Form 8-K.
Sincerely,
/s/ BPM LLP
San Jose, California
bpmcpa.com